Share Name Share Symbol Market Type Share ISIN Share Description
Benchmark Holdings Plc LSE:BMK London Ordinary Share GB00BGHPT808 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.50 0.83% 60.50 58.00 63.00 63.00 61.50 61.50 43,845 16:35:20
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 105.6 -22.6 -5.3 - 405

Benchmark Holdings PLC Listing of existing senior secured NOK bond

30/03/2021 7:00am

UK Regulatory (RNS & others)

Benchmark (LSE:BMK)
Historical Stock Chart

From Mar 2021 to May 2021

Click Here for more Benchmark Charts.


RNS Number : 8812T

Benchmark Holdings PLC

30 March 2021

30 March 2021

Benchmark Holdings plc

("Benchmark" or the "Company")

Listing of existing senior secured NOK bond ISIN NO 0010858210

Benchmark, the aquaculture biotechnology company, notifies that further to the announcement made on 13 June 2019, the Company has today listed its existing NOK 850 million senior secured floating rate bond (the "bond") on the Oslo Stock Exchange. The listing of the bond satisfies the last remaining condition under the terms of the bond. As previously announced, the bond has a coupon of three months NIBOR* + 5.25% p.a. with quarterly interest payments and matures in June 2023.

A copy of the prospectus which was approved by the NFSA, the Norwegian Financials Supervisory Authority, on 11th March 2021 is available at

*The three month NIBOR (Norwegian Interbank Offered Rate) stood at 0.38% as at 29 March 2021.


 Benchmark Holdings plc                            Tel: +44(0) 20 3696 0630 
 Trond Williksen, CEO 
 Septima Maguire, CFO 
 Ivonne Cantu, Investor Relations 
 Numis (Broker and NOMAD)                          Tel: +44(0) 20 7260 1000 
 James Black, Freddie Barnfield, Duncan Monteith 
 MHP Communications                                Tel: +44(0) 20 3128 8742 
 Katie Hunt, Reg Hoare, Alistair de Kare-Silver 

About Benchmark

Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability. We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out. Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), diets and probiotics and sea lice treatments. Find out more at

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

March 30, 2021 02:00 ET (06:00 GMT)

1 Year Benchmark Chart

1 Year Benchmark Chart

1 Month Benchmark Chart

1 Month Benchmark Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210516 16:00:10